Literature DB >> 21557211

Actin-independent exclusion of CD95 by PI3K/AKT signalling: implications for apoptosis.

Mathieu Pizon1, Hariniaina Rampanarivo, Sébastien Tauzin, Benjamin Chaigne-Delalande, Sophie Daburon, Michel Castroviejo, Patrick Moreau, Jean-François Moreau, Patrick Legembre.   

Abstract

The immune system eliminates infected or transformed cells through the activation of the death receptor CD95. CD95 engagement drives the recruitment of the adaptor protein Fas-associated death domain protein (FADD), which in turn aggregates and activates initiator caspases-8 and -10. The CD95-mediated apoptotic signal relies on the capacity to form the CD95/FADD/caspases complex termed the death-inducing signalling complex (DISC). Cells are classified according to the magnitude of DISC formation as either type I (efficient DISC formation) or type II (inefficient). CD95 localised to lipid rafts in type I cells, whereas the death receptor was excluded from these domains in type II cells. Here, we show that inhibition of both PI3K class IA and serine-threonine kinase Akt in type II cells promoted the redistribution of CD95 into lipid rafts, DISC formation and the initiation of the apoptotic signal. Strikingly, these molecular events took place independently of CD95L and the actin cytoskeleton. Overall, these findings highlight that the oncogenic PI3K/Akt signalling pathway participates in maintaining cells in a type II phenotype by excluding CD95 from lipid rafts.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21557211     DOI: 10.1002/eji.201041078

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-11-07       Impact factor: 5.922

Review 2.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

Review 3.  CD95-mediated cell signaling in cancer: mutations and post-translational modulations.

Authors:  Sébastien Tauzin; Laure Debure; Jean-François Moreau; Patrick Legembre
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

4.  Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation.

Authors:  Zhen-Tang Jing; Wei Liu; Shu-Xiang Wu; Yun He; Yan-Ting Lin; Wan-Nan Chen; Xin-Jian Lin; Xu Lin
Journal:  J Immunol       Date:  2018-08-31       Impact factor: 5.422

5.  The effect of sea anemone (H. magnifica) venom on two human breast cancer lines: death by apoptosis.

Authors:  Mahnaz Ramezanpour; Karen Burke da Silva; Barbara J S Sanderson
Journal:  Cytotechnology       Date:  2013-08-30       Impact factor: 2.058

Review 6.  Life in the Fas lane: differential outcomes of Fas signaling.

Authors:  Elizabeth Brint; Grace O'Callaghan; Aileen Houston
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

7.  Hepatitis B Spliced Protein (HBSP) Suppresses Fas-Mediated Hepatocyte Apoptosis via Activation of PI3K/Akt Signaling.

Authors:  Shu-Xiang Wu; Wan-Nan Chen; Zhen-Tang Jing; Wei Liu; Xin-Jian Lin; Xu Lin
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

8.  Involvement of CD95 and ligand in CD4+ T-cell and CD8+ T-cell depletion and hepatic cytolysis in patients with chronic viral hepatitis B.

Authors:  Franklin S Azebaze Agueguia; Paul Talla; Marie C Okomo Assoumou; Graeme B Jacobs; Cedric H Mbakam; Elise Guiedem; Martha Tongo Mesembe; Emilia Lyonga; George Mondinde Ikomey
Journal:  Afr J Lab Med       Date:  2021-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.